LASIK Eye Surgery Devices Market - By Product, By Application, By End Use - Global Forecast, 2025 - 2034

LASIK Eye Surgery Devices Market Size

The global LASIK eye surgery devices market was valued at USD 1.9 billion in 2024. The market is expected to reach from USD 2 billion in 2025 to USD 3.3 billion in 2034, growing at a CAGR of 5.8% during the forecast period, according to the latest report published by Global Market Insights Inc. The high market growth is attributed to the technological advancements in LASIK platforms, growing preference for minimally invasive vision correction, rising prevalence of refractive errors, and expanding availability of refractive surgery centers, among other contributing factors.

LASIK eye surgery devices are specialized ophthalmic systems that are utilized to reshape the cornea in order to correct the refractive errors like myopia, hyperopia, and astigmatism. They typically include excimer lasers and femtosecond lasers. These devices enable precise corneal ablation, flap creation, and customized vision correction procedures.
 

The leading players in the LASIK eye surgery devices market are Alcon, BAUSCH & LOMB, Johnson & Johnson, NIDEK, and ZEISS. These firms are able to keep their competitive advantage through constant product innovation, presence in the global market, and large-scale investments in research and development.
 

The market has increased from USD 1.6 billion in 2021 and reached USD 1.8 billion in 2023, with the historic growth rate of 4.7%. The market growth was driven by the rising refractive errors, increasing adoption of advanced laser technologies, and growing patient preference for permanent vision correction.
 

Moreover, the rising global incidence of myopia, hyperopia, and astigmatism continues to fuel demand for vision correction procedures. For instance, the International Myopia Institute reports that approximately 30% of the global population is currently myopic, a figure projected to reach nearly 50%, about 5 billion people by 2050.
 

Prevalence is highest in East and Southeast Asia, where rates range from 80% to 90%, while the U.S. has also seen myopia nearly double to 42% over the past three decades. Increasing screen exposure, younger-age onset, and an expanding ageing population further widen the patient pool, thereby accelerating the uptake of LASIK systems across clinics and ambulatory centers.
 

Furthermore, innovations such as femtosecond lasers, wavefront-guided systems, and topography-guided LASIK improve accuracy and safety. These technologies reduce complications and enhance patient outcomes. Continuous R&D investment accelerates device upgrades and replacement cycles.
 

LASIK Eye Surgery Devices Market Trends

The market is growing considerably with the shift toward customized and patient-specific LASIK, rapid adoption of femtosecond laser platforms, integration of AI and real-time imaging in LASIK systems, and increasing demand for portable and cost-effective LASIK devices in emerging markets, among other factors collectively driving industry growth.
 

• Wavefront-guided, topography-guided, and SMILE-based systems are facilitating the most highly personalized treatments. Clinics are increasingly adopting devices that can map the corneal aberrations more accurately. This development leads to better results for patients, fewer side effects such as halos/night glare, and increased usage of premium LASIK platforms. Customization is becoming a main factor that separates different device manufacturers.
   
• Small Incision Lenticule Extraction (SMILE) is emerging as a preferred option due to quicker recovery and no corneal flap requirement. Manufacturers are increasingly launching devices compatible with SMILE workflows. Surgeons are marketing these procedures as safer and more comfortable. The trend is expanding the scope of refractive surgery beyond traditional LASIK.
   
• Additionally, the smaller clinics and outpatient centers in Asia, MEA, and Latin America seek affordable, compact solutions. Manufacturers are responding with modular devices, leasing models, and service-based pricing. This trend helps penetrate price-sensitive regions while maintaining recurring revenue streams. It also supports adoption in tier-2 and tier-3 cities, thereby sustaining market growth.
   

LASIK Eye Surgery Devices Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

Based on the product, the LASIK eye surgery devices market is segmented into excimer laser and femtosecond laser. The excimer laser segment has asserted its dominance in the market by securing a significant market share of 53.9% in 2024 owing to its high precision in corneal ablation, proven clinical outcomes, and widespread adoption as the standard technology for refractive error correction procedures. The segment is expected to exceed USD 1.7 billion by 2034, growing at a CAGR of 5.4% during the forecast period.
 

On the other hand, the femtosecond laser segment is expected to grow with a CAGR of 6.1%. The growth of this segment is driven by its ability to deliver bladeless flap creation, improved safety profiles, faster recovery times, and rising adoption in advanced LASIK and SMILE procedures.
 

• The excimer laser segment continues to dominate the market. Excimer lasers are still the gold standard for accurate, minimally invasive tissue corneal reshaping. By their capability to provide one micron precision, the refractive outcomes are improved, and the complications are lowered. As a result, there is a strong uptake of these devices in high-volume LASIK centers.
   
• Moreover, newer excimer systems provide faster ablation speeds, more even ablation profiles, and highly accurate multidimensional eye-tracking. These improvements shorten the time of the operation and make it safer, thus clinics are more willing to upgrade their old systems. Replacement of devices is sustained by continuous innovation.
   
• The femtosecond laser segment held a revenue of USD 862 million in 2024, with projections indicating a steady expansion at 6.1% CAGR from 2025 to 2034. The segment is gaining traction as surgeons increasingly prefer its superior corneal incision accuracy and customizable flap parameters for optimized outcomes. Its expanding use in premium refractive procedures and integration with next-generation imaging systems is further strengthening its adoption across high-volume ophthalmic centers.
   

Based on application, the LASIK eye surgery devices market is segmented into myopia, hyperopia, astigmatism, and other applications. The myopia segment dominated the market in 2024, accounting for USD 643.1 million and is anticipated to grow at a CAGR of 6% during the forecast period.
 

• The number of myopic patients is increasing, especially in East Asia and urban regions worldwide. Increased screen time, early childhood near-work activities, and lifestyle changes contribute to higher incidence. This enlarges the potential patient base for LASIK procedures.
   
• Patients are increasingly informed about surgical alternatives to glasses and contact lenses. Awareness campaigns, online information, and physician recommendations encourage early intervention. LASIK for myopia correction is viewed as a convenient, long-term solution.
   
• The hyperopia segment accounted for significant revenue in 2024 and is anticipated to grow at a CAGR of 5.4% over the forecast period. The segment is experiencing growth as a result of increased awareness of farsightedness correction and the desire for better visual acuity without the need for glasses or contact lenses. The advances in laser precision and customized ablation profiles are making the treatment safer and more patients are satisfied, thus, the number of LASIK procedures for hyperopic patients is increasing.
   
• The astigmatism segment held a revenue of USD 477.6 million in 2024, with projections indicating a steady expansion at 6.3% CAGR from 2025 to 2034. The segment is expanding as more patients seek correction for irregular corneal curvature to achieve clear, distortion-free vision. Technological improvements in wavefront-guided and topography-assisted LASIK systems are increasing treatment accuracy and post-operative outcomes, boosting procedure demand.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the LASIK eye surgery devices market is classified into LASIK eye centers, hospitals, ambulatory surgical centers, ophthalmic clinics, and other end users. The LASIK eye centers segment dominated the market with a revenue share of 29.5% in 2024 and is expected to reach USD 1 billion within the forecast period.
 

• Clinics are increasingly investing in advanced laser platforms, imaging systems, and operation suites. High-end infrastructure attracts patients seeking safer and more precise vision correction. Upgrading equipment leads to recurring device sales and replacement cycles.
   
• LASIK procedures are predominantly outpatient, requiring minimal hospitalization. Surgeons and centers prefer efficient, high-throughput devices that maximize patient turnover. The trend supports the adoption of compact, user-friendly LASIK platforms.
   
• The hospitals segment held a revenue of USD 403.7 million in 2024, with projections indicating a steady expansion at 5.2% CAGR from 2025 to 2034. The segment is expanding as major healthcare facilities are progressively purchasing advanced LASIK systems to provide complete ophthalmic services. The presence of skilled surgeons, an integrated care infrastructure, and a high volume of patients make hospitals a major factor in driving market adoption.
   
• The ambulatory surgical centers segment accounted for significant revenue in 2024 and is anticipated to grow at a CAGR of 5.5% over the forecast period. Ambulatory surgical centers are driving market growth by providing convenient, cost-effective, and high-throughput LASIK procedures for elective vision correction. Their focus on specialized eye care, shorter procedure times, and personalized patient experiences enhances device adoption in this segment.
   

Looking for region specific data?

Download Free PDF

North America LASIK Eye Surgery Devices Market
 

North America dominated the market with the highest market share of 35.7% in 2024.
 

• The U.S. market was valued at USD 556.9 million and USD 575.8 million in 2021 and 2022, respectively. The market size reached USD 622.1 million in 2024, growing from USD 597.3 million in 2023, and is anticipated to grow at a CAGR of 4.6% between 2025 to 2034.
   
• North America has a significant population affected by myopia, hyperopia, and astigmatism, particularly among adults aged 20–50 years. Sedentary lifestyles and prolonged screen exposure are contributing to a steady increase in vision disorders. This expanding patient pool drives higher demand for LASIK procedures and associated devices across the U.S. and Canada.
   
• Furthermore, the region is home to numerous well-equipped and fully staff specialized eye hospitals, outpatient surgery centers, and ophthalmology clinics. The locals and visitors access to these facilities provides them with the opportunity to undergo widely available LASIK procedures. The level of hospital readiness and the comfort of patients are the main reasons for the high number of LASIK device sales.
   

Europe LASIK Eye Surgery Devices Market
 

Europe market accounted for USD 520 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Several European countries have public health campaigns emphasizing early detection and correction of refractive errors. Awareness about long-term eye health and preventive care encourages patients to consider LASIK. Such programs expand the market by increasing the patient pool seeking advanced surgical solutions.
   
• European clinics are rapidly adopting innovations like topography-guided, wavefront-optimized LASIK, and SMILE procedures. Surgeons prefer equipment that ensures safety, precision, and faster recovery. The emphasis on clinical excellence drives investments in modern LASIK devices across leading eye care centers.
   

Asia Pacific LASIK Eye Surgery Devices Market

The Asia Pacific market is anticipated to grow at the highest CAGR of 7% during the analysis timeframe.
 

• Increasing affluence in emerging APAC countries enables more patients to afford elective vision correction procedures. Rising disposable income and lifestyle awareness encourage adults to opt for LASIK, boosting procedural volumes and device adoption across urban and semi-urban areas.
   
• Additionally, patients in APAC are becoming increasingly aware of LASIK benefits through digital campaigns, social media, and physician recommendations. Cosmetic appeal, convenience, and long-term freedom from glasses drive adoption, particularly among young urban professionals.
   

Latin America LASIK Eye Surgery Devices Market

The Latin America market is experiencing robust growth over the analysis timeframe.
 

• In Latin America, the market is primarily driven by increasing urbanization and rising awareness of vision correction options among the middle-class population. Growing investments in private ophthalmic clinics and specialized refractive surgery centers are expanding access to advanced LASIK procedures.
   
• The region is also witnessing gradual adoption of modern technologies, such as wavefront-guided and femtosecond lasers, improving procedural safety and outcomes. Additionally, supportive financing options and rising disposable income are making elective surgeries more affordable. Medical tourism from neighbouring countries further contributes to higher procedural volumes, boosting demand for LASIK devices.
   

Middle East & Africa LASIK Eye Surgery Devices Market
 

The Middle East & Africa (MEA) market is experiencing robust growth over the analysis timeframe.
 

• The regional growth is driven by a growing demand for elective and lifestyle-oriented vision correction procedures among young urban populations. Increasing government initiatives to improve eye care infrastructure and support advanced ophthalmic technologies are enhancing market growth. The expansion of private eye care hospitals and specialized refractive surgery centers is improving accessibility to LASIK procedures.
   
• Rising medical tourism from neighbouring regions seeking high-quality yet cost-effective vision correction further boosts device adoption. Additionally, growing awareness of modern, minimally invasive laser treatments and improving affordability are encouraging patients to opt for LASIK surgeries.
   

LASIK Eye Surgery Devices Market Share

The market is highly competitive, characterized by the presence of several global and regional players offering advanced laser platforms and integrated refractive solutions. Companies are focusing on technological innovation, product differentiation, and strategic partnerships to strengthen their market positions.
 

Continuous upgrades in excimer and femtosecond laser technologies, along with emerging solutions like SMILE and AI-assisted planning, are intensifying competition among manufacturers.
 

Key players include Alcon, BAUSCH & LOMB, Johnson & Johnson, NIDEK, and ZEISS, collectively accounting for ~68% of the total market share. These companies leverage strong brand recognition, extensive distribution networks, and robust after-sales support to maintain their leadership.
 

Meanwhile, smaller regional players compete by offering cost-effective or compact LASIK systems, targeting mid-tier clinics and emerging markets, creating a dynamic market landscape that balances innovation with affordability.
 

LASIK Eye Surgery Devices Market Companies

Few of the prominent players operating in the LASIK eye surgery devices industry include:
 

• Alcon
• Alna-Medicalsystem
• BAUSCH & LOMB
• COHERENT
• EXCELSIUS MEDICAL
• iVis Technologies
• Johnson & Johnson
• Kera Harvest
• LENSAR
• NIDEK
• OptoTech
• SCHWIND eye-tech-solutions
• Spectra-Physics
• ZEISS
• Ziemer Ophthalmic
  
  
   
• Alcon

Alcon offers a comprehensive portfolio of advanced LASIK devices, including femtosecond and excimer lasers, known for precision, reliability, and consistent clinical outcomes. Its global presence and strong brand reputation enable high adoption across leading ophthalmic centers. Additionally, Alcon provides integrated solutions with robust training and support programs, enhancing surgeon confidence and patient satisfaction.
 

• BAUSCH & LOMB

Bausch & Lomb combines long-standing expertise in ophthalmic care with user-friendly LASIK platforms that emphasize safety, efficiency, and cost-effectiveness. Its devices are designed for high surgical throughput and minimal maintenance, appealing to both large hospitals and smaller clinics. The company also focuses on extensive surgeon education and post-sales support, strengthening loyalty and market penetration.
 

• Johnson & Johnson

Johnson & Johnson’s LASIK offerings, particularly the VISX excimer laser systems, are recognized for precision, customizable ablation profiles, and superior visual outcomes. Their strong clinical validation and global service network make them a preferred choice for high-volume refractive surgery centers. Continuous innovation and technology upgrades, including wavefront-guided and SMILE integration, further differentiate their products in the competitive landscape.

LASIK Eye Surgery Devices Industry News:

• In September 2025, Alcon announced the launch of its fully personalized LASIK treatment, Wavelight Plus, in the U.S. and Canada. The treatment utilized ray tracing technology through the sightmap diagnostic device, taking into account each patient’s unique eye shape and vision requirements. This innovation is anticipated to strengthen the company’s competitive position, enhanced precision and patient outcomes, and is expected to drive higher adoption of LASIK systems in premium ophthalmic centers.
   
• In January 2024, Bausch + Lomb Corporation announced that the U.S. Food and Drug Administration (FDA) had approved the TENEO Excimer Laser Platform for LASIK vision correction surgery for myopia and myopic astigmatism. It had been well received and was widely adopted in more than 50 countries worldwide, including now the U.S. This approval strengthened the company’s market presence, expanded its adoption in North America, and is expected to drive growth in the LASIK eye surgery devices market.
   
• In January 2024, ZEISS Medical Technology announced that the U.S. Food and Drug Administration (FDA) had approved the VISUMAX 800 with SMILE pro software for surgically treating nearsightedness, with or without astigmatism. The latest generation of femtosecond lasers from ZEISS entered the U.S. market after more than 8 million eyes had been treated with SMILE worldwide, demonstrating strong adoption in Asia and Europe. This approval enhanced ZEISS’s competitive edge, supported the expansion of SMILE procedures in North America, and is expected to drive growth in the market.
   

The LASIK eye surgery devices market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Excimer laser
• Femtosecond laser

Market, By Application

• Myopia
• Hyperopia
• Astigmatism
• Other applications

Market, By End Use

• LASIK eye centers
• Hospitals
• Ambulatory surgical centers
• Ophthalmic clinics
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE